242 related articles for article (PubMed ID: 12038811)
1. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
3. Hypergastrinemia and enterochromaffin-like cell hyperplasia.
Delle Fave G; Marignani M; Moretti A; D'Ambra G; Martino G; Annibale B
Yale J Biol Med; 1998; 71(3-4):291-301. PubMed ID: 10461360
[TBL] [Abstract][Full Text] [Related]
4. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid.
Annibale B; Azzoni C; Corleto VD; di Giulio E; Caruana P; D'Ambra G; Bordi C; Delle Fave G
Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1449-56. PubMed ID: 11742193
[TBL] [Abstract][Full Text] [Related]
5. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
Lehy T; Roucayrol AM; Mignon M
Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
[TBL] [Abstract][Full Text] [Related]
6. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Creutzfeldt W; Lamberts R
Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
[TBL] [Abstract][Full Text] [Related]
7. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and differential diagnosis of hypergastrinemia.
Arnold R
Wien Klin Wochenschr; 2007; 119(19-20):564-9. PubMed ID: 17985088
[TBL] [Abstract][Full Text] [Related]
9. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
Bardram L; Thomsen P; Stadil F
Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of ECL-cell abnormalities.
Hirschowitz BI
Yale J Biol Med; 1998; 71(3-4):303-10. PubMed ID: 10461361
[TBL] [Abstract][Full Text] [Related]
11. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
Hirschowitz BI; Worthington J; Mohnen J; Haber M
Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
[TBL] [Abstract][Full Text] [Related]
13. Discussion on the effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
Cattan D
Gastroenterology; 2003 Aug; 125(2):627; author reply 627-8. PubMed ID: 12891576
[No Abstract] [Full Text] [Related]
14. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa.
Borch K; Renvall H; Liedberg G; Andersen BN
Scand J Gastroenterol; 1986 Apr; 21(3):357-63. PubMed ID: 3715400
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
[TBL] [Abstract][Full Text] [Related]
16. [How to quantify argyrophil (enterochromaffin-like cells) cells in the fundus mucosa?].
Cadiot G; Willems G; Roucayrol AM; Lehy T
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):14C-18C. PubMed ID: 1916114
[No Abstract] [Full Text] [Related]
17. Pathology of endocrine cells in gastric mucosa.
Bordi C; Ravazzola M; de Vita O
Ann Pathol; 1983; 3(1):19-28. PubMed ID: 6838707
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
19. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
Lehy T; Cadiot G; Mignon M; Ruszniewski P; Bonfils S
Gut; 1992 Sep; 33(9):1275-9. PubMed ID: 1358767
[TBL] [Abstract][Full Text] [Related]
20. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]